AAAli Alhamza

Ali Alhamza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Alhamza has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Amy Malhowski

    Laboratory of Genome Integrity Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA

    1 shared publication
  • André Nussenzweig

    Laboratory of Genome Integrity Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA

    1 shared publication
  • Dharm S. Patel

    A Department of Molecular Biology and Biochemistry, Rutgers , The State University of New Jersey , Piscataway , NJ , USA

    1 shared publication
  • Francesca Cole

    Department of Epigenetics and Molecular Carcinogenesis, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center , Houston, TX 77030

    1 shared publication
  • Haiyan Zheng

    Biological Mass Spectrometry Facility Rutgers The State University of New Jersey Piscataway NJ USA

    1 shared publication
  • Joonyoung Her

    Department of Molecular Biology and Biochemistry Rutgers The State University of New Jersey Piscataway NJ USA

    1 shared publication

Latest Publications

  • 53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1

    by Minxing Li, Francesca Cole, Dharm S Patel, Sarah M Misenko, Joonyoung Her, Amy Malhowski, Ali Alhamza, Haiyan Zheng, Richard Baer, Thomas Ludwig, et al.

    BRCA1 mutations strongly predispose affected individuals to breast and ovarian cancer, but the mechanism by which BRCA1 acts as a tumor suppressor is not fully understood. Homozygous deletion of exon 2 of the mouse Brca1 gene normally causes embryonic lethality, but we show that exon 2‐deleted alleles of Brca1 are expressed as a mutant isoform that lacks the N‐terminal RING domain. This “RING‐less” BRCA1 protein is stable and efficiently recruited to the sites of DNA damage. Surprisingly, robust RAD51 foci form in cells expressing RING‐less BRCA1 in response to DNA damage, but the cells nonetheless display the substantial genomic instability. Genomic instability can be rescued by the deletion of Trp53bp1 , which encodes the DNA damage response factor 53BP1, and mice expressing RING‐less BRCA1 do not show an increased susceptibility to tumors in the absence of 53BP1. Genomic instability in cells expressing RING‐less BRCA1 correlates with the loss of BARD1 and a defect in restart of replication forks after hydroxyurea treatment, suggesting a role of BRCA1–BARD1 in genomic integrity that is independent of RAD51 loading. ![][1] BRCA1 protein lacking the N‐terminal RING domain is stable and supports RAD51 focus formation at DSBs. Cells with “RING‐less” BRCA1 nonetheless show genomic instability, likely because of BARD1 loss and impaired stalled replication fork restart. EMBO Reports (2016) 17: 1532–1541 [1]: /embed/graphic-1.gif